ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      5,718.57
      0.28%
      US Tech 100
      19,361.60
      0.21%
      Dow Jones
      42,124.65
      0.00%
      Brent Oil
      74.865
      1.53%
      Bitcoin
      63,507.62
      0.28%
      Registration Strip Icon for monitor Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. UK
      5. LSE

      6. Amica Sa (0LR0) Quote

      Amica Sa

      Amica Sa (0LR0)

      LSE
      122.60
      0.00
      ( 0.00% )
      Updated: 20:00:00
      Delayed by 15 minutes

      Empower your portfolio: Real-time discussions and actionable trading ideas.

      Premium

      Key stats and details

      Current Price
      122.60
      Bid
      0.00
      Ask
      0.00
      Volume
      0.00
      0.00 Day's Range 0.00
      122.60 52 Week Range 122.60
      Market Cap
      953.215M
      Previous Close
      122.60
      Open
      -
      Last Trade
      (O)
      Last Trade Time
      -
      Financial Volume
      -
      VWAP
      -
      Average Volume (3m)
      0.00
      Shares Outstanding
      7,775,000
      Dividend Yield
      -
      PE Ratio
      -238.29
      Earnings Per Share (EPS)
      -0.51
      Revenue
      2.84B
      Net Profit
      -4M

      About Amica Sa

      Sector
      Electric & Other Serv Comb
      Industry
      Electrical Equipment
      Website
      www.amica.com.pl
      Headquarters
      Wieliczka, Pol
      Founded
      1945
      Amica Sa is listed in the Electric & Other Serv Comb sector of the London Stock Exchange with ticker 0LR0. The last closing price for Amica was PLN122.60. Over the last year, Amica shares have traded in a share price range of PLN 122.60 to PLN 122.60.

      Amica currently has 7,775,000 shares outstanding. The market capitalization of Amica is PLN953.22 million. Amica has a price to earnings ratio (PE ratio) of -238.29.

      Ask ADVFN Intelligence (AI)

      0LR0 Latest News

      More News
      No news to show yet.
      PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
      100122.6122.6122.600DE
      400122.6122.6122.600DE
      1200122.6122.6122.600DE
      2600122.6122.6122.600DE
      5200122.6122.6122.600DE
      15600122.6122.6122.600DE
      26000122.6122.6122.60122.6DE

      Movers

      View all
      • Most Active
      • % Gainers
      • % Losers
      SymbolPriceVol.
      CLCOCloudcoco Group Plc
      0.155p
      (72.22%)
      		10M
      OBIOndine Biomedical Inc.
      6.875p
      (22.22%)
      		692.12k
      FABFusion Antibodies Plc
      3.95p
      (21.54%)
      		1.36M
      ALFAlternative Liquidity Fund Limited
      $ 0.045
      (20.00%)
      		11.43k
      ITIMItim Group Plc
      41.50p
      (18.57%)
      		65.71k
      AC8Acceler8 Ventures Plc
      90.00p
      (-43.75%)
      		1.58k
      CRCLCorcel Plc
      0.1025p
      (-21.15%)
      		23.41M
      FLKFletcher King Plc
      39.50p
      (-21.00%)
      		21.86k
      TM1Technology Minerals Plc
      0.10p
      (-20.00%)
      		11.94M
      CARDCard Factory Plc
      116.20p
      (-18.74%)
      		9.59M
      CLONClontarf Energy Plc
      0.0505p
      (-12.17%)
      		553.81M
      NTVONativo Resources Plc
      0.0025p
      (-3.85%)
      		315.99M
      MSMNMosman Oil And Gas Limited
      0.035p
      (-2.78%)
      		205.93M
      GBPGlobal Petroleum Limited
      0.14p
      (-6.67%)
      		165.52M
      MOSMobile Streams Plc
      0.1775p
      (-1.39%)
      		114.28M

      Discussion

      View Full Feed
      VoyagerDimension5 VoyagerDimension5 1 minute ago
      but if they buy material quarterly numbers have to be fully different next time…
      LWLG
      midastouch017 midastouch017 1 minute ago
      Projected Income of $325M to Can-Fite Over the Next 10 Years After Vetbiolix Exercised its Option and Licensed Piclidenoson for Veterinary Osteoarthritis


      In This Article:
      CANF
      +3.03%
      The agreement has been signed upon successful conclusion of a clinical st
      CANF
      midastouch017 midastouch017 1 minute ago
      Projected Income of $325M to Can-Fite Over the Next 10 Years After Vetbiolix Exercised its Option and Licensed Piclidenoson for Veterinary Osteoarthritis


      In This Article:
      CANF
      +3.03%
      The agreement has been signed upon successful conclusion of a clinical st
      CANF
      Zardiw Zardiw 2 minutes ago
      Where can Conservatives go for Real News?

      https://Patriot.TV is the go to place.

      And that's run by $CBMJ .... probably the most potential for growth there is.....

      They're just starting out, and are getting more viewers every day....

      Last r
      CBMJ
      Helter Skelter Helter Skelter 2 minutes ago
      $SLXN +38% @ 1.06 on NEWS/volume 😺
      SLXN
      Zardiw Zardiw 2 minutes ago
      Pretty crazy huh?.........Looks like we figured out alien tech from some crashed UFO's..........Bob Lazar was the one that blew the cover off of that.........

      Z
      fuagf fuagf 2 minutes ago
      Trump DOJ corruption -- There Used to Be Justice. Now We Have Bill Barr.

      "Did Bill Barr ‘corrupt’ the Justice Department?"

      The attorney general’s intervention in prosecutions of Mr. Trump’s allies is a new low.

      May 13, 2020

      https://static01
      THEBEASTMUGABI THEBEASTMUGABI 2 minutes ago
      I’ll have to mark this post, since it won’t bother you when it implodes I can publicly laugh at you. What a knucklehead.
      DJT
      JusticeWillWin JusticeWillWin 3 minutes ago
      COOP is a 100% BUY @ barchart.com

      See: https://www.barchart.com/stocks/quotes/COOP/opinion
      COOP
      tw0122 tw0122 3 minutes ago
      $10- $12 just a couple month back in July on ipo then furiously dumped. Pump and then quick dump to fleece shareholders again is highly probable. Don’t stick around too long
      SLXN
      I am done I am done 4 minutes ago
      $SSII Revolutionizing Surgery:
      https://finance.yahoo.com/news/revolutionizing-surgery-ss-innovations-international-123000647.html
      SSII
      MartinLutherKing MartinLutherKing 4 minutes ago
      MLGO China can challenge FOXO AI medical devices Made in the USA Brothers
      FOXO MLGO
      mattolotmoney mattolotmoney 4 minutes ago
      no need.you all will say it's Fake...I know what I own and I know what I made $$$$$$ and it was big ...
      INNDD
      I am done I am done 4 minutes ago
      $SSII Revolutionizing Surgery:
      https://finance.yahoo.com/news/revolutionizing-surgery-ss-innovations-international-123000647.html
      SSII
      surfkast surfkast 5 minutes ago
      No intelligence either. LOL
      IGPK
      Info3 Info3 5 minutes ago
      We will see in time, yes? How much time is the question
      BMXI
      Skynet11 Skynet11 5 minutes ago
      Yeah it's like there's two prices for whoever is buying/selling. One is 0.02 and the other 0.10. Every time. Isn't there a 60 day window from the time reporting is submitted to bring it current to the SEC?
      LBRMF
      Zardiw Zardiw 5 minutes ago
      Where can Conservatives go for Real News?

      https://Patriot.TV is the go to place.

      And that's run by $CBMJ .... probably the most potential for growth there is.....

      They're just starting out, and are getting more viewers every day....

      Last r
      CBMJ
      71chris71 71chris71 6 minutes ago
      T 53 but is there a particular motivation for today's messages? You seem very active here to me... This might suggest that there is something coming. Or it's just advertising
      CherryTree1 CherryTree1 6 minutes ago
      It is hard to believe England's MHRA will approve DCVAX and the FDA will not.
      NWBO
      abrooklyn abrooklyn 6 minutes ago
      Camtek Introduced 5th Generation of the Eagle System Supporting Expected Growth In 2025

      Source: PR Newswire (US)
      The first in a number of new products following recent years' R&D efforts

      MIGDAL HAEMEK, Israel, Sept. 24, 2024 /PRNewswire/ -- Camtek Ltd. (NASDAQ: C
      CAMT
      Info3 Info3 7 minutes ago
      I understand. Could they be lying possibly, but they are not in control of the audit. Management needs to communicate in a better way.
      BMXI
      Don Don 7 minutes ago
      https://www.otcmarkets.com/otcapi/company/financial-report/409186/content
      exwannabe exwannabe 7 minutes ago
      Thanks. Your document shows that the decision was on September 6, and it was published on the 10th.
      But what about that latest inspection date of Feb 2023?
      NWBO
      Itchy palm Itchy palm 8 minutes ago
      Good morning short bus . 😁

      Your Recent History

      LSE
      0LR0
      Amica
      Delayed Upgrade Clock